Xxera/openscience/retractions

Record #34759

Anticancer Effect of Rosiglitazone, a PPAR-γ Agonist against Diethylnitrosamine-Induced Lung Carcinogenesis

Yanqiao Wu, Nagaraja Sreeharsha, Sanjay Sharma, Anurag Mishra, Avinash Kumar Singh, Shiva Kumar Gubbiyappa

Journal

Publisher

American Chemical Society (ACS)

Original paper date

Mar 4, 2020

Original DOI

10.1021/acsomega.9b04357

Country

Institution

Intensive Care Unit, People’s Hospital of Ningjin County, Ningjin County, Shandong province 253400, China · Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia · NMIMS, School of Pharmacy and Technology Management, Shirpur 425405, Maharashtra, India · School of Pharmacy, Suresh Gyan Vihar University, Jaipur 302017, Rajasthan, India · Department of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi 110062, India · School of Pharmacy, GITAM University, Hyderabad 530045, India

Open access

No

Article type

Research Article

Broad categories

(BLS) Biochemistry (BLS) Biology - Cancer (BLS) Toxicology

Citation lifecycle

How this paper is being cited

Pre-retraction

4

Same day

0

Post-retraction

10

% post-retraction

71.4%

~2.3 citations/yr before retraction · ~2.1 citations/yr after

— citing papers

Who is still citing this work

Loading…